MDCXW
Medicus Pharma Ltd. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.65
52W High
$2.50
52W Low
$0.31
50-Day MA
$2.50
200-Day MA
$2.50
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd. (MDCXW) is a forward-looking pharmaceutical company focused on the development and commercialization of groundbreaking therapies to meet pressing healthcare needs. With a well-defined pipeline bolstered by innovative research and strict adherence to regulatory standards, the company is adept at navigating the evolving medical landscape. Medicus Pharma is dedicated to improving patient outcomes while simultaneously creating sustainable value for its investors, positioning itself as a key player in the pharmaceutical sector.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -2865.00% |
| Return on Assets | -278.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.03 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $50.34M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MDCXW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026